The effect of the IL-6 monoclonal blocker on the course of aseptic femoral head necrosis in the experiment (pilot study)

Background There is currently no pathogenetically based treatment for aseptic necrosis of the femoral head. One of the most promising areas of possible targeted therapy is the use of genetically engineered drugs, including monoclonal blockers of proinflammatory cytokines, aimed at inhibiting infla...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nikita A. Shabaldin, Anna V. Sinitskaya, Lyudmila N. Igisheva, Lev A. Bogdanov, Andrey V. Shabaldin
Formato:	Artigo
Idioma:	Inglês
Publicado:	Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics 2024-06-01
Series:	Гений oртопедии
Assuntos:	aseptic necrosis genetically engineered drugs osteodestruction il-6 monoclonal blocker osteoblastogenesis osteoclastogenesis osteoinduction anti-inflammatory therapy
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!